Literature DB >> 31889656

Geometric Pattern of Proximal Landing Zones for Thoracic Endovascular Aortic Repair in the Bovine Arch Variant.

Massimiliano M Marrocco-Trischitta1, Moad Alaidroos2, Rodrigo M Romarowski3, Francesco Secchi4, Paolo Righini5, Mattia Glauber6, Giovanni Nano7.   

Abstract

OBJECTIVE: The aim was to investigate whether the "bovine" aortic arch (i.e. arch variant with a common origin of the innominate and left carotid artery (CILCA)) is associated with a consistent geometric configuration of proximal landing zones for thoracic endovascular aortic repair (TEVAR).
METHODS: Anonymised thoracic computed tomography (CT) scans of healthy aortas were reviewed to retrieve 100 cases of CILCA. Suitable cases were stratified according to type 1 and 2 CILCA, and also based on type of arch (I, II, and III). Further processing allowed calculation of angulation and tortuosity of the proximal landing zones. Centre lumen line lengths of each proximal landing zone were measured in a view perpendicular to the centre line. All geometric features were compared with those measured in healthy patients with a standard arch configuration (n = 60). Two senior authors independently evaluated the CT scans, and intra- and interobserver repeatability were assessed.
RESULTS: The 100 selected patients (63% male) were 71.4 ± 7.7 years old. Type 1 CILCA (62/100) was more prevalent than type 2 CILCA (38/100), and the two groups were comparable in age (p = .11). Zone 3 presented a severe angulation (i.e. > 60°), which was greater than in Zone 2 (p < .001), and a consistently greater tortuosity than Zone 2 (p = .003). This pattern did not differ between type 1 and type 2 CILCA. A greater tortuosity was also observed in Zone 0, which was related to increased elongation of the ascending aorta (i.e. Zone 0), than the standard configuration. The CILCA had an overall greater elongation, and Zone 2 also was specifically longer. When stratifying by type of arch, reversely from Type III to Type I, the CILCA presented a gradual flattening of its transverse tract, which entailed a consistent progressive elongation (p = .03) and kinking of the ascending aorta, with a significant increase of Zone 0 angulation to even a severe degree (p = .001). Also, from Type III to Type I, Zone 2 presented a progressively shorter length (p = .004), which was associated with increased tortuosity (p < .05). Mean intra- and interobserver differences for angulation measurements were 1.4° ± 6.8° (p = .17) and 2.0° ± 10.1° (p = .19), respectively.
CONCLUSION: CILCA presents a consistent and peculiar geometric pattern compared with standard arch configuration, which provides relevant information for TEVAR planning, and may have prognostic implications.
Copyright © 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aortic angulation; Aortic elongation; Aortic tortuosity; Bovine arch; Proximal landing zones; Thoracic endovascular aortic repair

Mesh:

Year:  2019        PMID: 31889656     DOI: 10.1016/j.ejvs.2019.11.019

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  2 in total

1.  A Deep Learning-Based and Fully Automated Pipeline for Thoracic Aorta Geometric Analysis and Planning for Endovascular Repair from Computed Tomography.

Authors:  Simone Saitta; Francesco Sturla; Alessandro Caimi; Alessandra Riva; Maria Chiara Palumbo; Giovanni Nano; Emiliano Votta; Alessandro Della Corte; Mattia Glauber; Dante Chiappino; Massimiliano M Marrocco-Trischitta; Alberto Redaelli
Journal:  J Digit Imaging       Date:  2022-01-26       Impact factor: 4.056

2.  Feasibility and Safety of Cerebral Embolic Protection Device Insertion in Bovine Aortic Arch Anatomy.

Authors:  Ana Paula Tagliari; Enrico Ferrari; Philipp K Haager; Martin Oliver Schmiady; Luca Vicentini; Mara Gavazzoni; Marco Gennari; Lucas Jörg; Ahmed Aziz Khattab; Stefan Blöchlinger; Francesco Maisano; Maurizio Taramasso
Journal:  J Clin Med       Date:  2020-12-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.